Clinical Trial Update: Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating hydroxychloroquine in patients with X-linked Alport syndrome in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Alport Syndrome

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Shanghai Children's Hospital | Conditions: Alport Syndrome, X-Linked | Phase 2 | Status: COMPLETED